BACKGROUND	Adrenergic activation is thought to be an important determinant of outcome in subjects with chronic heart failure ( CHF ) , but baseline or serial changes in adrenergic activity have not been previously investigated in a large patient sample treated with a powerful antiadrenergic agent .\